Assessing the Usage Anesthesia in the Surgical Treatment of Diabetic Macular Edema

Abstract

Diabetes-related macular edema is a fast-spreading condition that has damaged the lives of countless people throughout the globe. The current incorporation of subthreshold micropulse laser has indicated the precedence of laser therapy in the treatment of diabetic macular edema; nonetheless, vitreoretinal surgery in conjunction with anesthetics correlates with early mitigation of damage to the fovea. Surgery is a delicate procedure that necessitates careful consideration of the types and locations of anesthetics used. Depending on the individual being treated, various drugs and methods may be necessary. For example, some individuals may be allergic to conventional anesthetics, resulting in more severe consequences. In the surgical treatment of diabetic macular edema, the topical anesthetic was utilized more frequently than subconjunctival anesthesia, according to the review’s statistical analysis. The examined literature indicated that topical lidocaine was the most employed anesthetic for vitreoretinal surgery; however, alternatives to lidocaine exist, and their effects should be investigated. Consequently, we would want to highlight the impacts of each of the several surgical medications and anesthetics used to treat diabetic macular edema.